Genetron Nov 4, 2021 Genetron Gets CE Mark for Cancer Genomic Profiling Test Oct 22, 2021 Genetron Health, Fosun Ink Commercialization Deal for Seq-MRD Test in China Sep 27, 2021 Genetron Health, Impact Therapeutics Partner for Anti-Cancer Drug, CDx Development Jul 30, 2021 In Brief This Week: Day One, Sophia Genetics, Genetron Health, Global Cancer Technology Jul 29, 2021 Genetron Health Partners with Guizhou Local Government for Liver Cancer Early Screening Project Jul 13, 2021 Genetron Health Receives CE Mark for Lung Cancer Sequencing Assay May 13, 2021 Genetron Health, Siemens Healthineers Partner to Promote Lung Cancer Molecular Testing in China Mar 25, 2021 Genetron Health Updates Data from Prospective Liquid Biopsy Liver Cancer Screening Study Premium Feb 12, 2021 In Brief This Week: Roche, Novartis, Basilea Pharmaceutica, Revolution Medicines, Genetron Health Breaking News Marengo Therapeutics Begins Phase I/II Trial of Selective T-Cell-Targeted Antibody Janssen, Legend Biotech's Carvykti Bests Chemo in Earlier-Line Multiple Myeloma Trial In Brief This Week: PreludeDx, Johnson & Johnson, Syros, Magenta, Merck NICE Backs Gilead Sciences' Yescarta as Third-Line Option for Lymphoma Patients BMS Eyeing Breyanzi Indications in CLL, SLL After Positive Trial Data Enhertu Approved in Europe for HER2-Low Metastatic Breast Cancer